SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-21-020383
Filing Date
2021-04-23
Accepted
2021-04-23 17:11:54
Documents
7
Period of Report
2021-06-04

Document Format Files

Seq Description Document Type Size
1 DEF 14A axsm-def14a_20210423.htm DEF 14A 2003053
2 GRAPHIC gh5mvsbfcd3b000002.jpg GRAPHIC 420983
3 GRAPHIC gh5mvsbfcd3b000005.jpg GRAPHIC 453250
4 GRAPHIC gh5mvsbfcd3b000003.jpg GRAPHIC 77559
5 GRAPHIC gh5mvsbfcd3b000006.jpg GRAPHIC 310207
6 GRAPHIC gh5mvsbfcd3b000004.jpg GRAPHIC 45933
7 GRAPHIC gh5mvsbfcd3b000001.jpg GRAPHIC 19151
  Complete submission text file 0001564590-21-020383.txt   3832067
Mailing Address 22 CORTLANDT STREET, 16TH FLOOR NEW YORK NY 10007
Business Address 22 CORTLANDT STREET, 16TH FLOOR NEW YORK NY 10007 (212) 332-3241
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

IRS No.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37635 | Film No.: 21850632
SIC: 2834 Pharmaceutical Preparations